1. Home
  2. CLST vs CELU Comparison

CLST vs CELU Comparison

Compare CLST & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Bancorp Inc.

CLST

Catalyst Bancorp Inc.

N/A

Current Price

$15.05

Market Cap

54.6M

Sector

N/A

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.60

Market Cap

50.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLST
CELU
Founded
1922
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.6M
50.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CLST
CELU
Price
$15.05
$1.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
6.8K
61.1K
Earning Date
01-22-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.60
N/A
Revenue
$11,340,000.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
$25.67
N/A
Revenue Growth
133.67
N/A
52 Week Low
$10.67
$1.00
52 Week High
$15.30
$4.35

Technical Indicators

Market Signals
Indicator
CLST
CELU
Relative Strength Index (RSI) 72.87 33.82
Support Level $15.02 $1.62
Resistance Level $15.30 $2.01
Average True Range (ATR) 0.04 0.13
MACD -0.03 -0.02
Stochastic Oscillator 89.33 2.82

Price Performance

Historical Comparison
CLST
CELU

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: